Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$731M |
| 2 |
Amazon
AMZN
|
+$442M |
| 3 |
S&P Global
SPGI
|
+$385M |
| 4 |
ARK Innovation ETF
ARKK
|
+$253M |
| 5 |
UnitedHealth
UNH
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.71B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$1.05B |
| 3 |
Apple
AAPL
|
+$629M |
| 4 |
US Bancorp
USB
|
+$575M |
| 5 |
Microsoft
MSFT
|
+$443M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.15% |
| 2 | Healthcare | 8.09% |
| 3 | Financials | 7.18% |
| 4 | Industrials | 6.24% |
| 5 | Consumer Discretionary | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMU
5226
DELISTED
MFS High Yield Municipal Trust
CMU
| $30.6K | ﹤0.01% |
9,790
-53
| -0.5% | -$173 |
|
|
THRD
5227
DELISTED
Third Harmonic Bio
THRD
| $30.6K | ﹤0.01% |
4,793
-2,570
| -35% | -$15.7K |
|
|
JBIO
5228
Jade Biosciences
JBIO
$1.32B
| $30.6K | ﹤0.01% |
64
-56
| -47% | -$30.3K |
|
|
GTHX
5229
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $30.6K | ﹤0.01% |
21,241
-9,392
| -31% | -$18.2K |
|
5230
Karyopharm Therapeutics
KPTI
$44.4M
| $30.4K | ﹤0.01% |
1,512
-1,636
| -52% | -$36.7K |
|
5231
USCF Midstream Energy Income Fund
UMI
$504M
| $30.4K | ﹤0.01% |
860
| – | – |
|
5232
Silvercrest Asset Management
SAMG
$77.6M
| $30.2K | ﹤0.01% |
1,900
-2,076
| -52% | -$40.1K |
|
5233
PDS Biotechnology
PDSB
$40.9M
| $30.1K | ﹤0.01% |
5,967
-11,274
| -65% | -$61.8K |
|
5234
X4 Pharmaceuticals
XFOR
$421M
| $30.1K | ﹤0.01% |
921
-714
| -44% | -$31.1K |
|
5235
IHS Holding
IHS
$2.79B
| $29.8K | ﹤0.01% |
5,375
-27,400
| -84% | -$203K |
|
5236
AlTi Global
ALTI
$476M
| $29.6K | ﹤0.01% |
4,253
-4,540
| -52% | -$33.7K |
|
5237
iShares MSCI Norway ETF
ENOR
$100M
| $29.6K | ﹤0.01% |
1,266
| – | – |
|
|
CARM
5238
DELISTED
Carisma Therapeutics
CARM
| $29.6K | ﹤0.01% |
6,987
-3,611
| -34% | -$22.9K |
|
|
STRR
5239
DELISTED
Star Equity Holdings
STRR
| $29.5K | ﹤0.01% |
6,027
-2
| -0% | -$10 |
|
5240
Cartesian Therapeutics
RNAC
$265M
| $29.5K | ﹤0.01% |
927
-603
| -39% | -$20.1K |
|
5241
Vista Gold
VGZ
$326M
| $29.3K | ﹤0.01% |
72,176
-251
| -0.3% | -$123 |
|
|
MRSN
5242
DELISTED
Mersana Therapeutics
MRSN
| $29.2K | ﹤0.01% |
921
-3,195
| -78% | -$152K |
|
|
LX
5243
LexinFintech Holdings
LX
$242M
| $29.2K | ﹤0.01% |
13,206
-648
| -5% | -$1.56K |
|
|
VALN
5244
Valneva
VALN
$541M
| $29.2K | ﹤0.01% |
2,520
| – | – |
|
|
LL
5245
DELISTED
LL Flooring Holdings, Inc.
LL
| $29.1K | ﹤0.01% |
9,171
+475
| +5% | +$1.71K |
|
5246
Full House Resorts
FLL
$90.5M
| $28.9K | ﹤0.01% |
6,779
-6,769
| -50% | -$37K |
|
|
CCRD
5247
DELISTED
CoreCard
CCRD
| $28.9K | ﹤0.01% |
1,443
-1,570
| -52% | -$35K |
|
|
CGO
5248
Calamos Global Total Return Fund
CGO
$130M
| $28.8K | ﹤0.01% |
3,296
+1
| +0% | +$9 |
|
5249
Tenaya Therapeutics
TNYA
$165M
| $28.8K | ﹤0.01% |
11,298
-6,066
| -35% | -$25.4K |
|
5250
Angi Inc
ANGI
$186M
| $28.8K | ﹤0.01% |
1,455
-5,341
| -79% | -$153K |
|
Similar funds
Wells Fargo's Q3 2023 Portfolio in Review
As of Q3 2023, Wells Fargo held 7,828 positions worth $341B, down 5.8% from $362B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wells Fargo's Q3 2023 filing shows 318 new, 2,125 increased, 4,030 reduced and 353 closed positions. Its largest new stake was TKO Group: 129,045 shares worth $10.8M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.71B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q3 2023 buy was TKO Group: 129,045 shares worth $10.8M.
- Wells Fargo added most to iShares Core MSCI EAFE ETF in Q3 2023, an estimated $731M increase.
- Wells Fargo's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.71B.
- Wells Fargo fully exited PG&E Corporation in Q3 2023, selling an estimated $86.2M.
- Wells Fargo's ten largest holdings make up 18% of its $341B portfolio in Q3 2023.
- Wells Fargo opened 318 new positions and closed 353 in Q3 2023.
- Wells Fargo's portfolio value fell 5.8% quarter-over-quarter to $341B.
Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.